We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Potential Drug Target To Slow Lymphoma Tumor Growth

News   Apr 08, 2020 | Original story from Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

 
A Potential Drug Target To Slow Lymphoma Tumor Growth

Left, lymph node from a non-lymphoma bearing control mouse. Right, vascular tree in lyph nodes from a lymphoma-bearing mouse. Credit: Rehm, Höpken, Gerhardt Labs, MDC

 
 
Advertisement
 

RELATED ARTICLES

Gut-Directed Astrocytes Dampen Inflammation in the Brain

News

Evidence has shown that astrocytes can also actively promote neurodegeneration, inflammation, and neurological diseases. Now, a team has shown that a specific astrocyte sub-population can do the opposite, instead serving a protective, anti-inflammatory function based on signals regulated by the bacteria that reside in the gut.

READ MORE

Cross Reactivity Seen Between SARS-CoV-2 and Antibodies to 2003 SARS Outbreak Virus

News

A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa.

READ MORE

FDA Approves Vericiguat for Use in Patients With Heart Failure

News

The US Food and Drug Administration (FDA) has approved the cardiovascular drug vericiguat. The drug is a once-daily oral treatment for patients with worsening chronic heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE